/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo

Neoscope

Topic

Latest Stories

Mr T Cell
2.11.21, 4:54 PM EST on neoscope
Study: One Particular Vaccine Protects Against Deadly New COVID Variants
Round 12
2.11.21, 3:42 PM EST on neoscope
After Second Death, Experts Fear New Ebola Outbreak
School Supplies
Updated 2.11.21, 2:54 PM EST on neoscope
Fauci: We're Now Testing Whether COVID Vaccines Work on Kids
Futurism
Updated 2.11.21, 2:23 PM EST on neoscope
CDC: People Who Have Been Fully Vaccinated Don't Need to Quarantine
Rewriting History
Updated 2.11.21, 12:20 PM EST on neoscope
WHO Investigators Find Evidence COVID Was Circulating in China Long Before Pandemic
Criminal Dose
2.11.21, 10:21 AM EST on neoscope
Doctor Fired for Giving Out Vaccine Doses That Were About to Expire
Counting Steps an...
2.10.21, 6:07 PM EST on neoscope
NASA Is Using Fitbits to Prevent COVID Spread Among Astronauts
What Luck
2.10.21, 4:00 PM EST on neoscope
Mutated COVID Virus Evolved Inside One Person, Scientists Believe
Warp Speed
2.9.21, 12:14 PM EST on neoscope
Pfizer Says It Can Cut Vaccine Manufacturing Time in Half
Guess WHO
2.9.21, 9:56 AM EST on neoscope
WHO Investigators: "Extremely Unlikely" That COVID Escaped From Chinese Lab
Worm Bodies
Updated 2.8.21, 3:50 PM EST on neoscope
Biologist Deliberately Infects Himself With 50 Hookworms
Political Loss
Updated 2.8.21, 3:18 PM EST on neoscope
Congressman Who Criticized COVID Lockdown Dies From COVID
  • Previous
  • 1
  • ...
  • 137
  • 138
  • 139
  • ...
  • 215
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.